SCHEMBL4083350

SCHEMBL4083350

Nc1cc(-c2nnn[nH]2)ccc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.39
TP53 P04637 2/20 0.39
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37
ALDH1A1 P00352 4/20 0.35
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
HPGD P15428 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NTRK1 P04629 1/20 0.35
CYP3A4 P08684 1/20 0.34
MAPK1 P28482 1/20 0.34
IKBKB O14920 2/20 0.34
MAPT P10636 3/20 0.34
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4399156 0.86 ALDH1A1 (0.52) TSHRTP53CA12CA1CA2
SCHEMBL703287 0.84 AHR (0.48) ALDH1A1NPC1RAB9AHPGDIKBKB
Hydrochloric Acid SCHEMBL16176998 0.82 TDP1 (0.46) TSHRTP53ALDH1A1NPC1RAB9A
SCHEMBL10321032 0.79 ALDH1A1 (0.48) TSHRALDH1A1NPC1RAB9AHPGD
SCHEMBL26230907 0.79 ALDH1A1 (0.46) CA12CA1CA2CA9ALDH1A1
SCHEMBL10145320 0.79 HSD17B10 (0.53) TP53NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL4029411 0.79 TDP1 (0.32) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL20339943 0.79 NPBWR1 (0.40) ALDH1A1HPGDIKBKBMEN1KMT2A
Hydrochloric Acid SCHEMBL952763 0.78 HSD17B10 (0.51) TP53NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL23291740 0.76 KDM4E (0.33) MAPTKDM4EL3MBTL1HRH1NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203692-A1 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION 2009-08-13 US disclosed
EP-1885362-A2 NOVEL CHEMICAL COMPOUNDS Smithkline Beecham Corporation (US) 2008-02-13 EP disclosed
WO-2006127458-A2 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2006-11-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203692-A1 NOVEL CHEMICAL COMPOUNDS HIPK3, HIPK1, HIPK4 TSHR 4599/4885TP53 2984/4885CA12 4671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.